ClariVest Asset Management’s Surmodics SRDX Stock Holding History

ClariVest Asset Management’s Portfolio SRDX Stock Details SRDX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-9,000	Closed	-$411K	–	714
2019 Q3	$411K	Sell	9,000 -200	-2%	-$8.72K	0.01%	431
2019 Q2	$397K	Sell	9,200 -8,100	-47%	-$342K	0.01%	381
2019 Q1	$752K	Sell	17,300 -4,974	-22%	-$253K	0.02%	426
2018 Q4	$1.05M	Sell	22,274 -2,789	-11%	-$167K	0.02%	388
2018 Q3	$1.87M	Sell	25,063 -1,300	-5%	-$89.5K	0.03%	331
2018 Q2	$1.46M	Buy	+26,363	New	+$1.22M	0.03%	386
2014 Q2	–	Sell	-3,451	Closed	-$78K	–	621
2014 Q1	$78K	Sell	3,451 -2,136	-38%	-$52.2K	﹤0.01%	429
2013 Q4	$136K	Sell	5,587 -493	-8%	-$11.6K	0.01%	393
2013 Q3	$145K	Buy	6,080 +293	+5%	+$6.28K	0.01%	384
2013 Q2	$116K	Buy	+5,787	New	+$145K	0.01%	376

Other funds holding SRDX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Trigran Investments Northbrook, Illinois $545M AUM 56.2% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

ClariVest Asset Management's SRDX Position: Q4 2019 in Review

ClariVest Asset Management sold out of Surmodics (SRDX) in Q4 2019, closing a stake of 9,000 shares — an estimated $411K sold.

ClariVest Asset Management first reported a position in SRDX in Q2 2013 and held it in 10 quarters. The position peaked at $1.87M in Q3 2018. 143 funds tracked by Wall St. Rank hold SRDX as of Q4 2019.

ClariVest Asset Management reported no remaining Surmodics position as of Q4 2019 after selling out during the quarter.
ClariVest Asset Management sold 9,000 Surmodics shares in Q4 2019, an estimated $411K.
ClariVest Asset Management first reported a position in Surmodics in Q2 2013 and held it in 10 quarters.
ClariVest Asset Management's Surmodics position peaked at $1.87M in Q3 2018.
143 funds tracked by Wall St. Rank held Surmodics as of Q4 2019.

Based on ClariVest Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.